Michael Joseph Borowitz MD
Anatomic Pathology, Clinical Pathology
Professor of Pathology, Professor of Oncology, Johns Hopkins University School of Medicine; Director, Division of Hematologic Pathology, Co-director, Genes to Society, Deputy Director, Education, Department of Pathology, Deputy Director, Clinical Affairs, Department of Pathology
Join to View Full Profile
600 N Wolfe StBaltimore, MD 21287
Phone+1 410-955-2660
Dr. Borowitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Borowitz is a pathologist in Baltimore, MD and is affiliated with multiple hospitals in the area, including Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center. He received his medical degree from Duke University School of Medicine and has been in practice 40 years. He specializes in hematopathology.
Education & Training
Duke University HospitalResidency, Pathology-Anatomic and Clinical, 1977 - 1981
Duke University School of MedicineClass of 1977
Certifications & Licensure
DC State Medical License 2015 - 2024
MD State Medical License 1993 - 2024
FL State Medical License 2015 - 2017
NC State Medical License 1977 - 2002
American Board of Pathology Anatomic Pathology & Clinical Pathology
Publications & Presentations
PubMed
- The real-world application of T-cell receptor constant beta-1 chain antibody assay in cutaneous T-cell lymphoma.Olivia Pierog, Taylor Craig, Jacky Jennings, Michael J Borowitz, Ananya Munjal
British Journal of Haematology. 2025-03-24 - Reply to: Accurate Determinants of Outcome in ALL.Ti-Cheng Chang, Wenan Chen, Chunxu Qu, Zhongshan Cheng, Abdelrahman Elsayed
Journal of Clinical Oncology. 2025-03-10 - 1 citationsHarnessing the Power of Generative Artificial Intelligence in Pathology Education: Opportunities, Challenges, and Future Directions.Matthew J Cecchini, Michael J Borowitz, Eric F Glassy, Rama R Gullapalli, Steven N Hart
Archives of Pathology & Laboratory Medicine. 2025-02-01
Journal Articles
- Genomic and Outcome Analyses of Ph-like ALL in NCI Standard-Risk Patients: A Report from the Children's Oncology GroupMichael J Borowitz, Nyla A Heerema, Brent L Wood, Elizabeth A Raetz, Stephen P Hunger, Andrew J Carroll, Mignon L Loh, Cheryl L Willman, Kelly W Maloney, Blood
- Genomic Analyses Identify Recurrent MEF2D Fusions in Acute Lymphoblastic LeukaemiaMichael Borowitz, Hagop M Kantarjian, Cheryl L Willman, Stephen P Hunger, Selina M Luger, Clara D Bloomfield, Brent Wood, Jerald P Radich, Marina Konopleva, Stephen J ..., Nature
Abstracts/Posters
- A Phase 2 Trial of Inotuzumab Ozogamicin (InO) in Children and Young Adults with Relapsed or Refractory (R/R) CD22+ B-Acute Lymphoblastic Leukemia (B-ALL): Results fro...Michael J. Borowitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- FLT3 Inhibitor Correlative Laboratory Assays Impact Outcomes in KMT2A-Rearranged Infant Acute Lymphoblastic Leukemia (ALL) Patients Treated with Lestaurtinib: AALL0631...Michael J. Borowitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Outcome in Adolescent and Young Adult (AYA) Patients Compared to Younger Patients Treated for High-Risk B-Lymphoblastic Leukemia (HR B-ALL): Report from the ChildrenÍs...Michael J. Borowitz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
Novel Subtypes in B Progenitor Acute Lymphoblastic LeukemiaDecember 12th, 2018
Acute Leukemia Workups, from Top to BottomMay 17th, 2017
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/michael-borowitz
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
